CTOs on the Move

SurgiMa

www.surgima.com

 
SurgiMa is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.surgima.com
  • 809 San Antonio Rd Ste 1
    Palo Alto, CA USA 94303
  • Phone: 650.494.0210

Executives

Name Title Contact Details

Similar Companies

Nextremity Solutions

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready® products for various musculoskeletal applications and for the benefit of our industry partners. The Companys procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

IDEAL LIFE

IDEAL LIFE, INC. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

QApel Medical, Inc.

In the simplest sense, we`re a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers.

PAVmed

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

Sanuwave

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE`s portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body`s normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.